decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Clinical Lab Services / Fraud alerts / Unbundling a blood test from an automated test and billing it separately
Subscribe or sign in to view the full article.
Article Overview
This article reviews a clinical laboratory fraud alert centered on unbundling part of an automated chemistry panel and billing a related test separately. It explains the concern in general terms, identifies the payer context that raised the issue, and shows why the topic matters to labs, billing staff, compliance teams, and auditors monitoring laboratory reimbursement practices.
Why This Topic Matters
Laboratory billing and compliance teams need to recognize how payer alerts address questionable reporting patterns in automated testing workflows. The article is relevant to anyone monitoring lab reimbursement, fraud alerts, and billing integrity for clinical chemistry services.
Article Sections
-
Unbundling a blood test from an automated test and billing it separately
Overview of the laboratory billing concern and the payer alert that brought it to attention. The section focuses on automated chemistry testing, separate reporting practices, and financial implications.
What You Will Learn
- The general laboratory billing issue described in the fraud alert
- How payer scrutiny can arise around automated testing and separate reporting
- Why the topic is relevant to compliance and reimbursement oversight
- The broader financial impact of questioned laboratory billing practices
Who Should Read This
- Clinical laboratory billing staff
- Compliance officers
- Medical coders
- Revenue cycle teams
- Auditors
- Healthcare fraud and abuse investigators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com